Canopy Growth Corp has lost its lead, GMP says

Aug 17 17:08 2019 Print This Article

Following a quarter that came in softer than expected, GMP Securities analyst Ryan Macdonell has cut his price target on Canopy Growth Corp (Canopy Growth Corp Stock Quote, Chart, News TSX:WEED) On Wednesday, Canopy reported its Q1, 2020 results. The company lost $1.28-billion on net revenue of $90.5-million, a topline that was up 249 per […]

The post Canopy Growth Corp has lost its lead, GMP says appeared first on Cantech Letter.

Read More

About Article Author

Cantech Letter

Founded in 2008 by Nick Waddell, Cantech Letter is an online magazine focusing on Canadian technology. The site has grown into one of the most popular and respected financial sites in Canada, and was described by Canadian Business Magazine as “one of Canada’s premier technology newsletters”. Waddell, who is Senior Editor, is routinely called on by the mainstream media for perspective on Canadian technology, and has been featured on BNN, CTV News Channel, and the CBC program “The Lang and O’Leary Exchange” in addition to mainstream print media such as The Guardian, The International Business Times, The Globe and Mail, Macleans, The Waterloo Record , Canadian Business, Slate, and Business Insider. You can email Nick at nick@cantechletter.com Cantech Letter is focused on those companies listed on the TSX and TSXV Technology, Cleantech and Life Sciences Sectors. Each year we present the Cantech Letter Awards, which honor Canada’s Top Technology Stock and Top Technology Stock Executive.

Related Items

Some CBD vapes contain street drug instead of the real thing

Jay Jenkins says he hesitated when a buddy suggested they vape CBD. “It’ll relax you,” the friend assured. The vapour that Jenkins inhaled didn’t relax him. After two puffs, he ended up in a coma. That’s because what he was vaping didn’t have any CBD, the suddenly popular compound extra ...

Shambhala 2020 dates and tix sales announced

Shambhala 2020 tix are on sale now! To get a taste of what’s in store for next year, make sure to check out the Aftermovie, which was also released today. It’s almost as mind-bendingly trippy as the festival and will give anyone that sees it a serious sense of FOMO. 2019 Aftermovie It starts in ...

Vape Crisis Hits Fever Pitch as AP Reports on ‘Synthetic Marijuana’ in CBD Vapes

On Sept. 16, the Associated Press reported on the tale of Jay Jenkins, a South Carolina man who took two puffs of what he thought was a CBD vaporizer before he ended up the Lexington Medical Center. He suffered from acute respiratory failure and went into a coma. Thankfully, he came out of the co ...

How the Associated Press collected information on CBD vapes

The cannabis extract CBD is marketed as a healing remedy that, unlike its cousin marijuana, doesn’t get users high. As demand increases, however, some vapes marketed as delivering an inhalable form of CBD in fact contain dangerous, illegal synthetic marijuana. As part of an investigation into CBD ...

BC Bud is losing out to Alberta

It wasn’t too long ago that BC was the undisputed capital of cannabis in Canada. The province is famous for having some of the best growers in the world, and it’s the home of BC Bud, after all. With the International Cannabis Business Conference having made its stop in Vancouver over the last ...

Organigram is ready for a breakout, Beacon says

Beacon Securities analyst Russell Stanley continues to be bullish on Organigram Holdings (Organigram Holdings Stock Quote, Chart News TSX:OGI), saying that the Moncton, New Brunswick, cannabis company looks ready for a breakout. On Monday, Organigram reported that it had received Health Canada appr ...

Canopy Growth Corp has never been in better shape, Mark Zekulin says

Canopy Growth Corp (Canopy Growth Corp Stock Quote, Chart, News TSX:WEED) may be in search mode for a new CEO at the moment but Mark Zekulin has nothing but praise for his company. There has been a gloomy picture painted by WEED’s share price of late, but the current CEO thinks Canopy is in great ...

Five Canadian pot stocks to buy for triple-digit returns in 2020

Canadian pot stocks. Dead money? The clouds have moved in over the Canadian cannabis space. Lackluster results from presumptive leader Canopy Growth Corp and a full-blown scandal via CannTrust Holdings have combined with a hundred smaller cuts to sink the returns for hot money investors used to wha ...

Biotech penny stock Antibe Therapeutics has a huge upside: Echelon

Echelon Wealth Partners analyst Douglas Loe is holding steady on his investment thesis for clinical stage drug developer Antibe Therapeutics (Antibe Therapeutics Stock Quote, Chart, News TSXV:ATE), maintaining in a client update on Wednesday his “Speculative Buy” recommendation and $1.40 target ...

Raymond James launches coverage of Profound Medical Corp with a $4.00 target

Raymond James analyst Rahul Sarugaser thinks Profound Medical Corp (Profound Medical Corp Stock Quote, Chart, News TSX:PRN) is profoundly undervalued. In a research report to clients today, the analyst initiated coverage of the Toronto-based medical device company with an “Outperform” rating an ...